Sargent Bickham Lagudis’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | $58.3K | Hold |
202
| – | – | ﹤0.01% | 418 |
|
2022
Q3 | $58K | Sell |
202
-20
| -9% | -$5.74K | 0.01% | 386 |
|
2022
Q2 | $63K | Buy |
222
+83
| +60% | +$23.6K | 0.01% | 379 |
|
2022
Q1 | $36K | Hold |
139
| – | – | ﹤0.01% | 519 |
|
2021
Q4 | $31K | Hold |
139
| – | – | ﹤0.01% | 541 |
|
2021
Q3 | $25K | Hold |
139
| – | – | ﹤0.01% | 571 |
|
2021
Q2 | $28K | Hold |
139
| – | – | ﹤0.01% | 564 |
|
2021
Q1 | $30K | Hold |
139
| – | – | ﹤0.01% | 528 |
|
2020
Q4 | $33K | Hold |
139
| – | – | ﹤0.01% | 485 |
|
2020
Q3 | $38K | Hold |
139
| – | – | ﹤0.01% | 422 |
|
2020
Q2 | $40K | Hold |
139
| – | – | ﹤0.01% | 383 |
|
2020
Q1 | $33K | Hold |
139
| – | – | ﹤0.01% | 392 |
|
2019
Q4 | $30K | Hold |
139
| – | – | ﹤0.01% | 461 |
|
2019
Q3 | $24K | Hold |
139
| – | – | ﹤0.01% | 449 |
|
2019
Q2 | $25K | Hold |
139
| – | – | ﹤0.01% | 456 |
|
2019
Q1 | $26K | Buy |
139
+20
| +17% | +$3.74K | ﹤0.01% | 481 |
|
2018
Q4 | $20K | Hold |
119
| – | – | ﹤0.01% | 490 |
|
2018
Q3 | $23K | Hold |
119
| – | – | ﹤0.01% | 480 |
|
2018
Q2 | $20K | Hold |
119
| – | – | ﹤0.01% | 486 |
|
2018
Q1 | $19K | Hold |
119
| – | – | ﹤0.01% | 486 |
|
2017
Q4 | $18K | Hold |
119
| – | – | ﹤0.01% | 514 |
|
2017
Q3 | $18K | Hold |
119
| – | – | ﹤0.01% | 516 |
|
2017
Q2 | $15K | Hold |
119
| – | – | ﹤0.01% | 525 |
|
2017
Q1 | $13K | Hold |
119
| – | – | ﹤0.01% | 554 |
|
2016
Q4 | $9K | Hold |
119
| – | – | ﹤0.01% | 579 |
|
2016
Q3 | $10 | Hold |
119
| – | – | ﹤0.01% | 585 |
|
2016
Q2 | $10K | Hold |
119
| – | – | ﹤0.01% | 554 |
|
2016
Q1 | $9K | Buy |
+119
| New | +$9K | ﹤0.01% | 583 |
|